Lollini PL - Search Results

1

Forni G, Curcio C, Spadaro M, Iliffe J, Quaglino E, Di Carlo E, Musiani P, Lollini PL. Forni G, et al. Among authors: lollini pl. Int Immunopharmacol. 2003 Aug;3(8):1151-8. doi: 10.1016/S1567-5769(03)00026-2. Int Immunopharmacol. 2003. PMID: 12860170 Review.

2

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. Di Carlo E, et al. Blood. 2001 Jan 15;97(2):339-45. doi: 10.1182/blood.v97.2.339. Blood. 2001. PMID: 11154206 Free article. Review. No abstract available.

3

Antitumor vaccines: is it possible to prevent a tumor?

Lollini PL, Forni G. Lollini PL, et al. Cancer Immunol Immunother. 2002 Oct;51(8):409-16. doi: 10.1007/s00262-002-0293-3. Epub 2002 Jun 25. Cancer Immunol Immunother. 2002. PMID: 12202901 Free PMC article. Review.

4

Immunoprevention of colorectal cancer: a future possibility?

Lollini PL, De Giovanni C, Nicoletti G, Di Carlo E, Musiani P, Nanni P, Forni G. Lollini PL, et al. Gastroenterol Clin North Am. 2002 Dec;31(4):1001-14. doi: 10.1016/s0889-8553(02)00054-7. Gastroenterol Clin North Am. 2002. PMID: 12489274 Review.

5

Cancer immunoprevention: tracking down persistent tumor antigens.

Lollini PL, Forni G. Lollini PL, et al. Trends Immunol. 2003 Feb;24(2):62-6. doi: 10.1016/s1471-4906(02)00030-3. Trends Immunol. 2003. PMID: 12547501 Review.

6

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.

Curcio C, Di Carlo E, Clynes R, Smyth MJ, Boggio K, Quaglino E, Spadaro M, Colombo MP, Amici A, Lollini PL, Musiani P, Forni G. Curcio C, et al. Among authors: lollini pl. J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426. J Clin Invest. 2003. PMID: 12697735 Free PMC article.

7

Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Iezzi M, Ricci C, Astolfi A, Croci S, Marangoni F, Musiani P, Forni G, Lollini PL. Nanni P, et al. Among authors: lollini pl. Int J Cancer. 2003 Jun 20;105(3):384-9. doi: 10.1002/ijc.11092. Int J Cancer. 2003. PMID: 12704673 Free article.

8

LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.

Cappello P, Triebel F, Iezzi M, Caorsi C, Quaglino E, Lollini PL, Amici A, Di Carlo E, Musiani P, Giovarelli M, Forni G. Cappello P, et al. Among authors: lollini pl. Cancer Res. 2003 May 15;63(10):2518-25. Cancer Res. 2003. PMID: 12750275

9

Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.

Nanni P, Nicoletti G, De Giovanni C, Croci S, Astolfi A, Landuzzi L, Di Carlo E, Iezzi M, Musiani P, Lollini PL. Nanni P, et al. Among authors: lollini pl. Cancer Res. 2003 Jun 1;63(11):2728-32. Cancer Res. 2003. PMID: 12782574

10

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Quaglino E, Rolla S, Iezzi M, Spadaro M, Musiani P, De Giovanni C, Lollini PL, Lanzardo S, Forni G, Sanges R, Crispi S, De Luca P, Calogero R, Cavallo F. Quaglino E, et al. Among authors: lollini pl. J Clin Invest. 2004 Mar;113(5):709-17. doi: 10.1172/JCI19850. J Clin Invest. 2004. PMID: 14991069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page